Related Experiment Video
Updated: May 11, 2026

Standardized Colon Ascendens Stent Peritonitis in Rats - a Simple, Feasible Animal Model to Induce Septic Acute Kidney Injury
Published on: February 15, 2022
Explainable Machine Learning Model for Predicting Persistent Sepsis-Associated Acute Kidney Injury: Development and
Wei Jiang1, Yaosheng Zhang2, Jiayi Weng3
1Department of Critical Care Medicine, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, China.
A machine learning model accurately predicts persistent sepsis-associated acute kidney injury (SA-AKI). This interpretable gradient boosting machine model outperforms the CCL14 biomarker for early SA-AKI prediction.
Area of Science:
- Nephrology
- Critical Care Medicine
- Data Science in Healthcare
Background:
- Persistent sepsis-associated acute kidney injury (SA-AKI) presents significant clinical challenges and poor outcomes.
- Early and accurate prediction of persistent SA-AKI is critical for timely intervention.
Purpose of the Study:
- To develop and validate an interpretable machine learning (ML) model for predicting persistent SA-AKI.
- To compare the diagnostic performance of the ML model against the urinary biomarker C-C motif chemokine ligand 14 (CCL14).
Main Methods:
- Utilized multiple retrospective and prospective cohorts, including MIMIC-IV, MIMIC-III, and e-ICU databases.
- Developed and validated 8 ML algorithms, selecting a gradient boosting machine (GBM) model based on performance metrics.
- Employed Shapley Additive Explanations (SHAP) for model interpretability and developed a web-based application for clinical use.
Main Results:
- The final interpretable GBM model, using 12 key clinical features, demonstrated high accuracy in predicting persistent SA-AKI across internal and external validation cohorts (AUCs ranging from 0.870 to 0.983).
- In a prospective cohort, the GBM model showed superior predictive performance compared to urinary CCL14 (AUC=0.852 vs. 0.821).
Conclusions:
- An interpretable GBM model effectively predicts persistent SA-AKI with strong validation across diverse cohorts.
- The developed ML model offers a promising alternative and outperforms the CCL14 biomarker for predicting persistent SA-AKI in clinical settings.
Related Concept Videos
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention

